Faheem Tahir

Contributing Author

Recent Articles by Faheem Tahir

Jan-24	Citi Lowers Its Price Target on Microsoft (MSFT) from $690 to $660, Reiterates a 'Buy' Rating MSFT Insider Monkey
Jan-24	NVIDIA (NVDA) CEO Jensen Huang Frames AI as the Largest Infrastructure Buildout in Human History NVDA Insider Monkey
Jan-24	Amazon.com (AMZN)'s E-Commerce Platform Faces Tariff-Related Price Spikes AMZN Insider Monkey
Jan-24	JPMorgan CEO Jamie Dimon Sees Rising Regulatory Risk for Card Networks Such as Visa (V) V Insider Monkey
Jan-24	The Procter & Gamble Company (PG) Reports Mixed Second-Quarter 2026 Results Amid Weak Consumer Spending PG Insider Monkey
Jan-24	UBS Reaffirms Its 'Neutral' Rating with a $280 Price Target on Apple (AAPL) AAPL Insider Monkey
Jan-24	The Coca-Cola Company (KO) Accelerates Consumer-Centric Execution and Enterprise-Wide Digital Transformation With Key Leadership Changes KO Insider Monkey
Jan-24	Guggenheim Reduces PT on Eli Lilly and Company (LLY) to $1,161, Reiterates 'Buy' Rating LLY Insider Monkey
Jan-24	Berkshire Hathaway (BRK-B) Looks to Exit Its 27.5% Stake in Kraft Heinz BRK-B Insider Monkey
Jan-24	Wolfe Research Flags Tax Refund Tailwinds as a Positive for Costco Wholesale (COST) COST Insider Monkey
Jan-21	Zimmer Biomet Holdings (ZBH)'s 2026 Expectations Remain Cautious Amid Internal Reset ZBH Insider Monkey
Jan-21	RBC Capital Bullish on Huntington Bancshares (HBAN) Amid Stable Regional Bank Fundamentals HBAN Insider Monkey
Jan-21	Wells Fargo Bullish on Masco (MAS) Ahead of Q4 2025 Results Announcement MAS Insider Monkey
Jan-21	JPMorgan Cautious on United Parcel Service (UPS) Amid Expected Share Pullback UPS Insider Monkey
Jan-21	Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies AMGN Insider Monkey
Jan-21	ISS Backs Kenvue (KVUE) Deal, Investors Debate Tylenol and Litigation Risks KVUE Insider Monkey
Jan-21	Leerink Bullish on Bristol-Myers Squibb Company (BMY) Amid Ample Pipeline Optionality in 2026 BMY Insider Monkey
Jan-21	Cautious Analyst Sentiment on Adobe (ADBE) Amid Intensifying Competition Across Core Creative Markets ADBE Insider Monkey
Jan-21	Merck & Co (MRK) to Generate $70 Billion in Revenue from Emerging Businesses By Mid-2030s MRK Insider Monkey
Jan-21	U.S. Bancorp (USB) Expands Capital Markets Reach With BTIG Deal USB Insider Monkey
Jan-21	Bernstein Remains Bullish on AT&T (T) Amid Rising Competition T Insider Monkey
Jan-21	Broader Analyst Sentiment Bullish on Adobe (ADBE) Amid Longer-Term Franchise Strength ADBE Insider Monkey
Jan-21	Broader Analyst Sentiment Bullish on Merck & Co. (MRK) Amid Tempered Short-Term Expectation and Long-Term Optimism MRK Insider Monkey
Jan-21	AbbVie (ABBV) Looks to Deepen Its Push Into Rapidly Growing Obesity-Treatment Market ABBV Insider Monkey
Jan-21	Barclays Remains Bullish on Micron Technology (MU) Amid Continued AI Momentum MU Insider Monkey
Jan-21	Morgan Stanley Remains Bullish on Bank of America (BAC) Following Strong Q4 Results BAC Insider Monkey
Jan-21	Truist Remains Cautious on JPMorgan Chase & Co. (JPM) Following Q4 2025 Results JPM Insider Monkey
Jan-21	Capital One Financial (COF) Closer to Ending Depositor Lawsuit With $425 Million Settlement Deal COF Insider Monkey
Jan-21	Citigroup (C) Signals Stabilizing Core Businesses and Progress on Strategic Streamlining C Insider Monkey
Jan-21	Bernstein Remains Bullish on T-Mobile US (TMUS) Amid Changing Competitive Dynamics Across U.S. Telecom TMUS Insider Monkey
Jan-18	Analysts Bullish on Meta Platforms (META) Amid AI Expansion and Long-Term Power Deals META Insider Monkey
Jan-18	Boston Scientific (BSX) Expands Urology Portfolio with Valencia Deal, Analysts Emphasize Organic Growth BSX Insider Monkey
Jan-18	Broader Anlayst Sentiment Positive on MercadoLibre (MELI) As AI Tailwinds Offset Rising Capital Expenditure MELI Insider Monkey
Jan-18	Uber Technologies (UBER) Confronts Critical Phoenix Trial Amid Thousands of Pending Sexual Assault Claims UBER Insider Monkey
Jan-18	Snowflake (SNOW) Eyes AI Data Cloud Expansion with Strategic Acquisition of Observe SNOW Insider Monkey
Jan-18	BNP Paribas Assumes Coverage of DoorDash (DASH), Assigns 'Outperform' Rating with $280 PT DASH Insider Monkey
Jan-18	Strong Analyst Sentiment on Microsoft (MSFT) Despite Price Target Cuts and Heavy AI Spend MSFT Insider Monkey
Jan-18	Strong Analyst Confidence in Alibaba Group Holding (BABA) Amid AI and Cloud Momentum BABA Insider Monkey
Jan-18	Street Remains Confident in Arista Networks (ANET) Amid AI Infrastructure Build Cycle Acceleration ANET Insider Monkey
Jan-18	Strong Analyst Sentiment on Advanced Micro Devices (AMD) Amid CES AI Processor Launches Despite Nvidia Competition AMD Insider Monkey
Jan-18	Truist Reduces PT on Flutter Entertainment plc (FLUT) from $280 to $260, Reiterates 'Buy' Rating FLUT Insider Monkey
Jan-18	Oppenheimer Lowers Its PT on Spotify Technology (SPOT) from $825 to $750, Reiterates 'Outperform' Rating SPOT Insider Monkey
Jan-18	HSBC Bullish on Netflix (NFLX) Growth Amid Monetization, International Expansion and Strategic Acquisitions NFLX Insider Monkey
Jan-18	Oracle (ORCL) Gains Analyst Support with Cloud Growth, AI Adoption, and Data Center Expansion ORCL Insider Monkey
Jan-18	WedBush Bullish on Sea Limited (SE) Amid Shopee Growth SE Insider Monkey
Jan-18	Strong Analyst Sentiment on ServiceNow (NOW) Amid Strengthened Pipeline and AI Tailwinds NOW Insider Monkey
Jan-18	Analysts Bullish on Broadcom (AVGO) Amid Strong AI Chip Outlook AVGO Insider Monkey
Jan-12	UBS and Citi Go Bullish on Gilead Sciences (GILD) GILD Insider Monkey
Jan-12	UBS and Citi Go Bullish on Gilead Sciences (GILD) GILD Insider Monkey
Jan-12	Shell plc (SHEL) Secures First Long-Term Vietnam Contract, Morgan Stanley Trims PT SHEL Insider Monkey
Jan-12	Analyst Sentiment on Verizon Communications (VZ) Improves Amid Steadier Growth and Defensible Cash Flows VZ Insider Monkey
Jan-12	Strong Analyst Sentiment on Anheuser-Busch (BUD) As It Expands U.S. Brewing Capacity and Reaquires Strategic Plant BUD Insider Monkey
Jan-12	Bernstein Raises PT on CVS Health (CVS) to $91, Reiterates 'Market Perform' Rating CVS Insider Monkey
Jan-12	Analysts Positive on PepsiCo (PEP) Amid Multi-Year, Industry-First Collaboration with NVIDIA and Siemens PEP Insider Monkey
Jan-12	Evercore ISI, BofA, and JPMorgan Reduce PT on The Progressive Corporation (PGR) Amid Slowing Industry Fundamentals PGR Insider Monkey
Jan-12	Freedom Finance Raises PT on PDD Holdings (PDD) to $170, Reiterates 'Buy' Rating PDD Insider Monkey
Jan-12	Sanofi (SNY) Reports Regulatory Win, Barclays Downgrades to 'Equal Weight' with EUR 85 PT SNY Insider Monkey
Jan-12	Scotiabank Reduces PT on AT&T (T) to $29.50, Reiterates 'Sector Perform' Rating T Insider Monkey
Jan-12	Jefferies Cautious on Adobe (ADBE) As It Updates Outlook on Software Sector ADBE Insider Monkey
Jan-12	Kosmos Energy (KOS) Shares Operational Update, Bernstein Remains Bullish KOS Insider Monkey
Jan-12	Blink Charging (BLNK) Gains Momentum Amid Ongoing Fast-Charging Network Expansion BLNK Insider Monkey
Jan-12	Canaan (CAN) Growth Momentum Strengthens Following 3.0 MW Proof-of-Concept Project Announcement CAN Insider Monkey
Jan-12	Morgan Stanley Reduces PT on Tenaya Therapeutics (TNYA), Keeps Constructive Stance on U.S. Small- to Mid-Cap Biotech TNYA Insider Monkey
Jan-12	Sangamo Therapeutics (SGMO) Shares Stabilize Amid Recent Key Pipeline Update SGMO Insider Monkey
Jan-12	Oncolytics Biotech (ONCY) Leadership Strengthens As Pelareorep Advances ONCY Insider Monkey
Jan-12	Immunic (IMUX) Reviews 2025 Performance and Highlights Upcoming Milestones, Shares Up 24.10% IMUX Insider Monkey
Jan-12	Werewolf Therapeutics (HOWL) Eyes 2026 Catalysts Following FDA Guidance and Encouraging INDUKINE Results HOWL Insider Monkey
Jan-11	Reviva Pharmaceuticals Holdings (RVPH) Records 37% in 2026 So far RVPH Insider Monkey
Jan-08	Stephens' Confidence in Wingstop (WING) Uplifted After a Challenging 2025 WING Insider Monkey
Jan-08	BMO Capital Raises PT on Texas Roadhouse (TXRH) from $155 to $170, Reiterates "Market Perform" Rating TXRH Insider Monkey
Jan-08	Bullish Analyst Sentiment on Restaurant Brands International (QSR) Amid Improving Burger King Momentum QSR Insider Monkey
Jan-08	Analysts Cautious on The Wendy's Company (WEN) Amid Cost and Margin Pressures WEN Insider Monkey
Jan-08	Cautiously Optimistic Analyst Sentiment on Yum! Brands (YUM) Amid Leadership Changes YUM Insider Monkey
Jan-08	Brinker International (EAT) Continues to Draw Analyst Attention Amid Strong Casual Dining Segment Outlook EAT Insider Monkey
Jan-08	TD Cowen Downgrades Domino's Pizza (DPZ) to 'Hold', Reduces PT to $460 DPZ Insider Monkey
Jan-08	Bernstein Reiterates 'Outperform' Rating on Chipotle Mexican Grill (CMG), Reduces PT from $50 to $40 CMG Insider Monkey
Jan-08	McDonald's Corporation (MCD) Eyes Balancing Value and Profit as Analysts Reassess Pricing Upside MCD Insider Monkey
Jan-08	Yum China Holdings (YUMC) Continues to Draw Analyst Attention Following Share Repurchase Agreements YUMC Insider Monkey
Jan-08	Cautious Analyst Sentiment on Papa John's (PZZA) As Refranchising and Cost Reductions Drive Strategy PZZA Insider Monkey
Dec-25	Analysts Confident in Harmonic (HLIT) Outlook As Video Business Divestiture Advances HLIT Insider Monkey
Dec-25	Entegris (ENTG) Management Confident in Future Growth Despite Bearish Sentiment from Goldman Sachs ENTG Insider Monkey
Dec-25	Uber and Lyft Partner With Baidu (BIDU) to Launch Driverless Taxi Trials in the UK BIDU Insider Monkey
Dec-25	Wells Fargo Bullish on Synaptics (SYNA) Due to Attractive Risk/Reward Profile SYNA Insider Monkey
Dec-25	Analyst Sentiment Positive on PDF Solutions (PDFS) Amid Strong Future Outlook PDFS Insider Monkey
Dec-25	Pegasystems (PEGA) Advances Agentic AI in Compliance Software Amid Intensifying Regulatory Demand PEGA Insider Monkey
Dec-25	Analysts Confident in NXP Semiconductors (NXPI) Amid Improving Outlook on Diversified Analog Semiconductor Market NXPI Insider Monkey
Dec-25	Analysts Confident in NXP Semiconductors (NXPI) Amid Improving Outlook on Diversified Analog Semiconductor Market NXPI Insider Monkey
Dec-21	Bullish Analyst Sentiment on Fulcrum Therapeutics (FULC) Following Positive Updates from Phase 1b PIONEER Study FULC Insider Monkey
Dec-21	Taysha Gene (TSHA) Hovers Around Its 52-Week High As It Continues to Advance Rett Syndrome Program TSHA Insider Monkey
Dec-21	High Analyst Confidence on Palvella Therapeutics (PVLA) Following Encouraging Phase 2 Data for QTORIN Rapamycin PVLA Insider Monkey
Dec-21	Gossamer Bio (GOSS) Sees Strong Analyst Confidence Amid Seralutinib Progress and Upcoming PROSERA Data GOSS Insider Monkey
Dec-21	Strong REZOLVE-AA Study Results Drive Analyst Confidence in Nektar Therapeutics (NKTR) NKTR Insider Monkey
Dec-21	Trevi Therapeutics (TRVI) Targets Next Phase of Growth with Leadership Change TRVI Insider Monkey
Dec-21	Analysts Remain Bullish on Seabridge Gold (SA) Amid KSM Project Progress SA Insider Monkey
Dec-21	TD Cowen Initiates Coverage on RAPT Therapeutics (RAPT) with a "Buy" RAPT Insider Monkey
Dec-21	Analysts Bullish as Ventyx Biosciences (VTYX) Advances Its Clinical and Strategic Initiatives VTYX Insider Monkey
Dec-21	Analyst Sentiment Remains Bullish on CytomX Therapeutics (CTMX) Amid CX-2051 Therapy Progress CTMX Insider Monkey
Dec-21	H.C Wainwright and Citizens Raise PT on DBV Technologies (DBVT) Following Phase 3 VITESSE Trial Result DBVT Insider Monkey
Dec-21	Compass Therapeutics' (CMPX) Tovecimig Drives Strong Analyst Sentiment CMPX Insider Monkey
Dec-17	Stifel Bullish on Equinox Gold (EQX) As Valentine Progress Accelerates EQX Insider Monkey

Faheem Tahir

Recent Articles by Faheem Tahir

Upgrade your FINVIZ experience